Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
The Food and Drug Administration requested that Allergan, a company that manufactures textured breast implants, voluntarily recall the devices on Wednesday, based on their link to an unusual form of cancer.
Why it matters: 573 cases and 33 deaths from anaplastic large cell lymphoma have been reported around the world, according to FDA data. Of the 573 cases, 481 have been attributed to the Allergan product.
Anaplastic large cell lymphoma is a cancer that affects the immune system. It is not breast cancer, but forms around the tissue of the implant.
- Of note: Women who have these implants, but go undiagnosed, should not have them removed. The recall is to only stop doctors from further using the implants.
- Symptoms include swelling and pain around the breasts. Fluid accumulation around the implant can also occur and should be drained and tested for cancer if symptoms persist, per the FDA.
- Taking out the implant and scar tissue can cure the cancer. The disease can be fatal if not detected early enough.
The big picture: Textured implants account for only about 5% of the implants used in the U.S. The product is more common in Europe, where it has already been recalled in many countries, the New York Times reports.
Allergan told the FDA it will remove BioCell textured breast implants and tissue expanders from the markets in which they're sold.
- A list of those models can be found here.